Great Valley Advisor Group Inc. Buys 66 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Great Valley Advisor Group Inc. increased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.7% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 2,543 shares of the medical equipment provider’s stock after buying an additional 66 shares during the period. Great Valley Advisor Group Inc.’s holdings in Intuitive Surgical were worth $1,249,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Massachusetts Financial Services Co. MA bought a new stake in Intuitive Surgical in the 3rd quarter valued at about $558,807,000. International Assets Investment Management LLC boosted its stake in shares of Intuitive Surgical by 49,383.6% in the third quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider’s stock valued at $535,788,000 after buying an additional 1,088,415 shares during the period. Strategic Financial Concepts LLC grew its position in Intuitive Surgical by 40,221.4% during the second quarter. Strategic Financial Concepts LLC now owns 266,121 shares of the medical equipment provider’s stock worth $1,184,000 after buying an additional 265,461 shares in the last quarter. Manning & Napier Advisors LLC bought a new position in Intuitive Surgical during the 2nd quarter worth $91,466,000. Finally, Assenagon Asset Management S.A. raised its holdings in Intuitive Surgical by 15.4% in the 2nd quarter. Assenagon Asset Management S.A. now owns 1,483,406 shares of the medical equipment provider’s stock valued at $659,893,000 after acquiring an additional 197,841 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analyst Ratings Changes

A number of research analysts recently commented on ISRG shares. The Goldman Sachs Group set a $604.00 price target on Intuitive Surgical in a research report on Friday, October 18th. Royal Bank of Canada raised their target price on shares of Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a report on Friday, October 18th. Oppenheimer reaffirmed a “market perform” rating on shares of Intuitive Surgical in a report on Friday, October 18th. Robert W. Baird lifted their price objective on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research note on Thursday, October 17th. Finally, BTIG Research set a $535.00 target price on Intuitive Surgical in a research note on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have issued a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $524.61.

Intuitive Surgical Price Performance

Intuitive Surgical stock opened at $536.55 on Tuesday. The business has a 50 day moving average of $505.63 and a 200-day moving average of $465.19. The company has a market capitalization of $191.11 billion, a P/E ratio of 86.26, a P/E/G ratio of 5.39 and a beta of 1.39. Intuitive Surgical, Inc. has a 1 year low of $304.50 and a 1 year high of $552.00.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The firm had revenue of $2.04 billion during the quarter, compared to analysts’ expectations of $2.01 billion. Equities analysts anticipate that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Insiders Place Their Bets

In other Intuitive Surgical news, EVP Robert Desantis sold 238 shares of the company’s stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $477.50, for a total transaction of $113,645.00. Following the sale, the executive vice president now owns 5,506 shares of the company’s stock, valued at approximately $2,629,115. This represents a 4.14 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, General Counsel Gary Loeb sold 300 shares of Intuitive Surgical stock in a transaction dated Monday, September 9th. The stock was sold at an average price of $475.00, for a total value of $142,500.00. Following the completion of the transaction, the general counsel now directly owns 1,595 shares of the company’s stock, valued at approximately $757,625. This trade represents a 15.83 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 50,539 shares of company stock valued at $26,112,364. 0.80% of the stock is currently owned by company insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.